|
|
|
Volumn 27, Issue 2, 2000, Pages 243-244
|
|
Basiliximab (Simulect): simplifying induction therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BASILIXIMAB;
HYBRID PROTEIN;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
ACUTE DISEASE;
ARTICLE;
DRUG INTERACTION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
NURSE ATTITUDE;
PATIENT SELECTION;
RENAL REPLACEMENT THERAPY;
TREATMENT OUTCOME;
ACUTE DISEASE;
ANTIBODIES, MONOCLONAL;
DRUG INTERACTIONS;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
NURSE'S ROLE;
PATIENT SELECTION;
RECOMBINANT FUSION PROTEINS;
RENAL DIALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0000060054
PISSN: 1526744X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
